Detalles de la búsqueda
1.
Phase II Study of Continued Trastuzumab Plus Irinotecan in Patients with HER2-positive Gastric Cancer Previously Treated with Trastuzumab (HGCSG 1201).
Oncologist
; 27(5): 340-e374, 2022 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35303078
2.
Multicenter, prospective, observational study of chemotherapy-induced dysgeusia in gastrointestinal cancer.
Support Care Cancer
; 30(6): 5351-5359, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35292848
3.
Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer.
BMC Cancer
; 17(1): 837, 2017 12 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29221445
4.
Open-label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron.
Cancer Sci
; 106(7): 891-5, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25872578
5.
Randomized controlled trial on the skin toxicity of panitumumab in Japanese patients with metastatic colorectal cancer: HGCSG1001 study; J-STEPP.
Future Oncol
; 11(4): 617-27, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25686117
6.
Technical difficulty according to location, and risk factors for perforation, in endoscopic submucosal dissection of colorectal tumors.
Surg Endosc
; 29(1): 133-9, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24993172
7.
[Clinical impact of addition of bevacizumab to the first-line chemotherapy regimen in the treatment of patients with metastatic colorectal cancer].
Gan To Kagaku Ryoho
; 41(9): 1113-7, 2014 Sep.
Artículo
en Japonés
| MEDLINE | ID: mdl-25248894
8.
Rescue technique using a diathermic dilator for an unremovable stent in malignant perihilar biliary obstruction.
Endoscopy
; 49(S 01): E42-E45, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28068701
9.
Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer.
Acta Oncol
; 51(7): 867-72, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22554343
10.
Phase II study of combined treatment with irinotecan and S-1 (IRIS) in patients with inoperable or recurrent advanced colorectal cancer (HGCSG0302).
Oncology
; 80(1-2): 70-5, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21659785
11.
Retrospective cohort study on the safety and efficacy of bevacizumab with chemotherapy for metastatic colorectal cancer patients: the HGCSG0801 study.
Jpn J Clin Oncol
; 41(4): 490-7, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21303790
12.
[A case of sigmoid colon cancer with temporary dysarthria associated with irinotecan].
Gan To Kagaku Ryoho
; 38(8): 1375-7, 2011 Aug.
Artículo
en Japonés
| MEDLINE | ID: mdl-21829085
13.
Combination therapy of bevacizumab with either S-1 and irinotecan or mFOLFOX6/CapeOX as first-line treatment of metastatic colorectal cancer (TRICOLORE): Exploratory analysis of RAS status and primary tumour location in a randomised, open-label, phase III, non-inferiority trial.
Eur J Cancer
; 154: 296-306, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34304054
14.
[A case of sigmoid colon cancer with lymphangitis carcinomatosa successfully treated with chemotherapies including molecular targeting drugs].
Gan To Kagaku Ryoho
; 37(3): 535-8, 2010 Mar.
Artículo
en Japonés
| MEDLINE | ID: mdl-20332699
15.
[Second-line chemotherapy for colorectal cancer].
Gan To Kagaku Ryoho
; 36(5): 721-5, 2009 May.
Artículo
en Japonés
| MEDLINE | ID: mdl-19461170
Resultados
1 -
15
de 15
1
Próxima >
>>